1202 ORAL ANTI-CD3 IMMUNOTHERAPY FOR HCV-NON-RESPONDERS IS...

1202 ORAL ANTI-CD3 IMMUNOTHERAPY FOR HCV-NON-RESPONDERS IS SAFE, PROMOTES REGULATORY T CELLS, AND DECREASES VIRAL LOAD AND LIVER ENZYME LEVELS: RESULTS OF A PHASE-2a PLACEBO-CONTROLLED TRIAL

Halota, W., Ferenzi, P., Kozielewicz, D., Dybowska, D., Lisovoder, N., Samira, S., Shalit, I., Ellis, R., Ilan, Y.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
58
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(13)61203-9
Date:
April, 2013
File:
PDF, 65 KB
english, 2013
Conversion to is in progress
Conversion to is failed